Results 1 to 10 of about 1,819,904 (233)

Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease. [PDF]

Catheter Cardiovasc Interv
O'Callaghan D, Rai H, Giacoppo D, Coughlan JJ, Durand R, Paradies V, Colleran R, Blake GJ, Alfonso F, Byrne RA.   +9 more
europepmc   +1 more source

Comparative efficacy of drug-coated balloons versus drug-eluting stents in treating <i>de novo</i> CAD in ACS. [PDF]

Br J Cardiol
Saluja S, Mannan F, Saleem M, El-Omar M, Khanfar A, Singh A, Keshavarzi F, Alawami M.   +7 more
europepmc   +1 more source

Durable versus biodegradable polymer drug-eluting stents in all-comers. [PDF]

Open Heart
Witzig T, Puricel S, Witzig A, Meier P, Arroyo D, Togni M, Cook S.   +6 more
europepmc   +1 more source

A risk prediction nomogram for in-stent restenosis in patients with coronary heart disease: first exploratory analysis based on the substrate materials of drug-eluting stents. [PDF]

Front Cardiovasc Med
Zhao Z, Li K, Tan K, Zhang R, Tian J, Li R, Li S, Liu S, Yu F, Xin H.   +9 more
europepmc   +1 more source

Drug-Coated Balloons Versus Drug-Eluting Stents for Large Vessel Coronary Artery Disease: A Meta-Analysis. [PDF]

J Cardiovasc Dev Dis
Zeng J, Liu Y, Zhao T, Yuan J, Yang W, Wang M.   +5 more
europepmc   +1 more source

Dedicated drug-eluting stents versus bare-metal stents for vertebral artery origin stenosis: a real-world single-center experience. [PDF]

BMC Neurol
Sun X, Wang L, Zhu R, Zhang Y, Liu X, Zhang Z.   +5 more
europepmc   +1 more source

Drug-eluting stents from cardiology to pneumonology. [PDF]

Future Cardiol
Zarogoulidis P, Huang H, Freitag L.
europepmc   +1 more source

Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort. [PDF]

Am Heart J Plus
Jariwala P, Vallapuri GS, Konda BKR, Jangam SK.   +3 more
europepmc   +1 more source

Safety, efficacy, OCT-assessed vascular healing and angiographic outcomes of polymer-free versus biodegradable-polymer drug-eluting stents in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]

Eur J Med Res
Abouelenien MM, Mekky ME, Bakry Z, Sawafta Y.   +3 more
europepmc   +1 more source

Impact of Nonadherence to Any Antiplatelet Therapy After PCI With Drug-Eluting Stents on Critical Outcomes. [PDF]

JACC Asia
Mori Y, Friede T, Hattori S, Yamaji K, Fukuma S.   +4 more
europepmc   +1 more source